Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2319-2013Class II

DeVilbiss Vacu-Aide QSU Suction Unit (Disposable Suction Container/Filter), 800 ML DISP Container...

Sunrise Medical, Inc. / initiated 2013-03-07 / Terminated

DeVilbiss Healthcare LLC began a recall of DeVilbiss Vacu-Aide QSU Suction Unit (Disposable Suction Container/Filter), 800 ML DISP Container, Unassembled, 800 ML DISP Container w/6' patient tubing, and... on . FDA classified it as Class II and gives the reason as "End users of the DeVilbiss Disposable Suction Container/Filter had exposed the bacterial filter cartridge to fluid, thereby occluding the filter and rendering it unusable". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2319-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Sunrise Medical, Inc.
Product
DeVilbiss Vacu-Aide QSU Suction Unit (Disposable Suction Container/Filter), 800 ML DISP Container, Unassembled, 800 ML DISP Container w/6' patient tubing, and 800 ML DISP Container w/6' patient tubing, assembled. DeVilbiss Vacu-Aide QSU Suction Unit (Disposable Suction Container/Filter) is used to remove fluids from the airway or respiratory support system and infectious materials from wounds. It is available for use by consumers by physician order.
Product code
JCX Apparatus, Suction, Ward Use, Portable, Ac-Powered
Reason for recall
End users of the DeVilbiss Disposable Suction Container/Filter had exposed the bacterial filter cartridge to fluid, thereby occluding the filter and rendering it unusable.
FDA root cause
Use error
Action
DeVilbiss Healthcare sent End users a field corrective action letter dated March 7, 2013, to all affected customers to reinforce the proper cleaning method. This letter is to inform you that we have come across cases where end users had exposed the bacterial filter cartridge in the disposable suction container to fluid, thereby occluding the filter and rendering it unusable Specifically what do you have to do when you receive a correction/recall notice? " The US FDA states in its correction/recall regulations that: "Consignees that receive a recall communication should immediately carry out the instructions set forth by the recalling firm and, where necessary, extend the recall to its consignees." "Enclosed you will find two Urgent Medical Device Correction letters addressed to DeVilbiss Dealer/Provider" and "DeVilbiss User" that we ask you read carefully. "It is important that you follow the actions outlined in these letters to ensure we can effectively disseminate this information to end-users. "To reach your direct accounts we ask that you send a copy of the "DeVilbiss User" letter to each of these end-users. We sincerely appreciate all of your efforts to ensure the safety of your customers that depend on DeVilbiss products. We thank you in advance for your assistance and apologize for any inconvenience that you may experience as a result of this situation. Should you have any questions or concerns, please contact DeVilbiss Healthcare Customer Service at 1-800-338-1988.
Quantity in commerce
112,849
Distribution
Worldwide Distribution - USA and the countries of Mexico and Canada.
Product codes and lots
Part Number 7305D-634 with model numbers 7305D-632, 7305D-633, and 7305D-633-25

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2319-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2319-2013Class IITerminatedVoluntary: Firm initiated